Tag: Ocean Biomedical
SEC filing of the week: Ocean Biomedical posts $8.42M loss in...
PROVIDENCE – Ocean Biomedical Inc. reported a loss of $8.42 million in the first quarter compared with a profit of $13 million the biopharmaceutical company...
New CEO, several board members to step down from Ocean Biomedical
PROVIDENCE – Four out of nine members of Ocean Biomedical Inc.'s board of directors, including the new CEO, are stepping down amidst a larger...
Ocean Biomedical faces Nasdaq delisting
PROVIDENCE – Ocean Biomedical Inc. is at risk of being kicked off the Nasdaq exchange for failing to file quarterly and other required financial...
Ocean Biomedical enters first in-human clinical trial
PROVIDENCE – Ocean Biomedical, a biopharmaceutical company launched out of Brown University, is entering its first in-human clinical trial with Virion Therapeutics LLC, a...
Ocean Biomedical discovers new therapy that can potentially kill cancerous cells
PROVIDENCE – Ocean Biomedical and Aesther Healthcare Acquisition Corp. announced the discovery of a therapy that could potentially kill glioblastoma and melanoma cells –...
Ocean Biomedical hopes to raise $22M going public
PROVIDENCE – Ocean Biomedical Inc. hopes to raise up to $22 million in an amended initial public offering filed with Securities and Exchange Commission...
- Featured Event -
